Secondary Pure Red Cell Aplasia During Daratumumab/ Hyaluronidase Therapy for Multiple Myeloma
Investigators discussed the potential link between secondary pure red cell aplasia and subcutaneous daratumumab/hyaluronidase formulation for multiple myeloma.
Unusual Clinical Presentation of Clear Cell Sarcoma in a Young Woman
A young woman presents with painless lumps to the emergency department and is later diagnosed with clear cell carcinoma.
Multidisciplinary Team Approach Is Integral to Oncology Care
Julie M. Vose, MD, MBA, discussed why the need for multidisciplinary care is so pertinent, and how it must continue even after treatment ends.
